Form 4: Yield10 Bioscience Director Jack W. Schuler Reports Sale of Shares

Director Jack W. Schuler reported the sale of 36,000 shares of Yield10 Bioscience, Inc. common stock at $0.20 per share on December 20, 2023.

Summary

• On December 20, 2023, Jack W. Schuler, a director of Yield10 Bioscience, Inc., sold 36,000 shares of common stock at a price of $0.20 per share.
• Following the transaction, Schuler directly owns 63,789 shares.
• Schuler also indirectly owns shares through the Jack W. Schuler Living Trust.
• A 1-for-24 reverse stock split was effected by the Issuer on May 2, 2024, and the reported amounts have been adjusted to reflect this split.
• The filing of this form was delayed due to an inadvertent administrative error.

Sentiment

Score: 4

Explanation: The sentiment is neutral to slightly negative due to the stock sale by a director and the late filing, which could raise concerns about internal controls. However, without additional context, it's difficult to assess the full impact.

Negatives

• The filing of this form was delayed due to an inadvertent administrative error.

Risks

• The late filing indicates a potential weakness in internal controls.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. These filings are closely monitored by investors to gauge sentiment and potential future actions of key individuals within the company.

Stakeholder Impact

• The stock sale by a director could be perceived negatively by shareholders.

Key Dates

Keywords

Form 4, Yield10 Bioscience, YTEN, Director, Jack W. Schuler, Stock Sale, Reverse Stock Split, Beneficial Ownership